ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

QNCX Quince Therapeutics Inc

1.06
-0.05 (-4.50%)
After Hours
Last Updated: 17:59:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Quince Therapeutics Inc QNCX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -4.50% 1.06 17:59:00
Open Price Low Price High Price Close Price Prev Close
1.06 1.05 1.1199 1.06 1.11
more quote information »

Recent News

Date Time Source Heading
4/01/202407:00BWQuince Therapeutics Provides Business Update and Reports..
2/22/202407:00BWQuince Therapeutics Launches Scientific Advisory Board
2/15/202416:00EDGAR2Form 8-K - Current report
2/15/202407:00BWQuince Therapeutics Appoints Former Reata Pharmaceuticals..
2/07/202416:05BWQuince Therapeutics to Present at Oppenheimer 34th Annual..
2/02/202417:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202416:01EDGAR2Form 8-K/A - Current report: [Amend]
1/04/202416:05BWQuince Therapeutics to Participate at Investor Events in..
1/03/202416:02EDGAR2Form 8-K - Current report
12/22/202316:08EDGAR2Form 8-K - Current report
12/14/202318:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202316:06EDGAR2Form 8-K - Current report
12/07/202318:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202313:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202317:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/24/202319:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/24/202319:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/23/202316:05EDGAR2Form 8-K - Current report
10/23/202307:00BWQuince Therapeutics Completes Acquisition of EryDel S.p.A.
9/28/202316:53DJNQuince Therapeutics to Advance Study of EryDex as FDA Lifts..
9/28/202316:05BWU.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s..
9/06/202307:18EDGAR2Form 8-K - Current report
9/06/202307:00BWQuince Therapeutics Appoints Dr. Charles S. Ryan as..
8/31/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/17/202318:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202317:05EDGAR2Form 8-K - Current report
8/10/202316:05BWQuince Therapeutics to Present at Sidoti Virtual Investor..
8/09/202318:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/09/202318:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/03/202316:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/24/202317:56BWQuince Therapeutics rileva EryDel SpA e il suo asset di fase..
7/24/202307:16EDGAR2Form 8-K - Current report
7/24/202307:00BWQuince Therapeutics to Acquire EryDel SpA and its Phase 3..

Your Recent History

Delayed Upgrade Clock